Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies
Top Cited Papers
Open Access
- 3 October 2024
- journal article
- review article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 24 (1) , 1-18
Abstract
Hypoxia is one of the defining characteristics of the tumor microenvironment (TME) in solid cancers. It has a major impact on the growth and spread of malignant cells as well as their resistance to common treatments like radiation and chemotherapy. Here, we explore the complex functions of hypoxia in the TME and investigate its effects on angiogenesis, immunological evasion, and cancer cell metabolism. For prognostic and therapeutic reasons, hypoxia identification is critical, and recent developments in imaging and molecular methods have enhanced our capacity to precisely locate underoxygenated areas inside tumors. Furthermore, targeted therapies that take advantage of hypoxia provide a potential new direction in the treatment of cancer. Therapeutic approaches that specifically target hypoxic conditions in tumors without causing adverse effects are being led by hypoxia-targeted nanocarriers and hypoxia-activated prodrugs (HAPs). This review provides an extensive overview of this dynamic and clinically significant area of oncology research by synthesizing current knowledge about the mechanisms of hypoxia in cancer, highlighting state-of-the-art detection methodologies, and assessing the potential and efficacy of hypoxia-targeted therapies.Keywords
Funding Information
- Narodowe Centrum Nauki (2020/39/B/NZ5/00745, 2020/39/B/NZ5/00745)
This publication has 160 references indexed in Scilit:
- Activation of the HIF pathway in cancerCurrent Opinion in Genetics & Development, 2001
- Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular AspectsJNCI: Journal of the National Cancer Institute, 2001
- Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau proteinNature Cell Biology, 2000
- Pimonidazole: A Novel Hypoxia Marker for Complementary Study of Tumor Hypoxia and Cell Proliferation in Cervical CarcinomaGynecologic Oncology, 1998
- Measurement of Tumor Oxygenation: A Comparison between Polarographic Needle Electrodes and a Time-Resolved Luminescence-Based Optical SensorRadiation Research, 1997
- Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adductsInternational Journal of Cancer, 1996
- Nicotinamide and Other Benzamide Analogs as Agents for Overcoming Hypoxic Cell Radiation Resistance in TumoursActa Oncologica, 1995
- A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.Molecular and Cellular Biology, 1992
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI: Journal of the National Cancer Institute, 1990
- Hypoxic Sensitizers — Implications for Radiation TherapyNew England Journal of Medicine, 1979